Matthias Van Woensel Ph.D Overview

  • Primary Position
  • Partner

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 2

  • Med. Deal Size

  • Med. Valuation

Matthias Van Woensel Ph.D General Information

Biography

Dr. Matthias Van Woensel serves as Partner at Droia Oncology Ventures. He serves as Board Member at Hillstar Bio. He is a recipient of VCU RDD Peter R. Byron Graduate Student Award. He serves as Board Member at Hyku.

Contact Information

Primary Position
Partner, Droia Ventures
Education
Katholieke Universiteit Leuven (KU Leuven, University of Leuven), Ph.D. (Doctor of Philosophy)
Katholieke Universiteit Leuven (KU Leuven, University of Leuven), MS (Master of Science)
Gender
Male
Email
ma
Phone
+32 02
Address
  • Da Vincilaan 1
  • 1930 Zaventem
  • Belgium
+32 02

Matthias Van Woensel Ph.D Positions (1)

Firm name Firm type Title Location Industry Since
Droia Ventures Investor Partner Luxembourg, Luxembourg Venture Capital

Matthias Van Woensel Ph.D Board Seats (2)

Company Industry Ownership Status Financing Status Location Since
Hillstar Bio Drug Discovery Privately Held (backing) Venture Capital-Backed Boston, MA
Hyku Biotechnology Privately Held (backing) Venture Capital-Backed Lexington, MA

Matthias Van Woensel Ph.D Lead Partner on Deals (1)

Matthias Van Woensel Ph.D has been the lead partner on 1 deal. Their latest deal was with Hyku, a biotechnology company. The deal was made for on 12-Nov-2024.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Hyku 12-Nov-2024 Seed Round Completed Biotechnology Lexington, MA

Matthias Van Woensel Ph.D Network (20)

Board Members (9)

Name Company Representing Location From
Laura Tadvalkar Ph.D Hyku RA Capital Management Lexington, MA
Robert Mabry Ph.D Hillstar Bio Self Boston, MA
Hillstar Bio Novo Holdings Boston, MA
Hyku Self Lexington, MA
Hyku Novartis Venture Fund Lexington, MA

Portfolio Executives (5)

Name Company Role Deal date Location
Keith Wilcoxen Ph.D Hyku Chief Scientific Officer 12-Nov-2024 Lexington, MA
Mark Mulvihill Ph.D Hyku Chief Scientific Officer 12-Nov-2024 Lexington, MA
Hyku Chief Executive Officer, President & Board Member 12-Nov-2024 Lexington, MA
Hyku Co-Founder, Acting Chief Executive Officer & Board Member 12-Nov-2024 Lexington, MA
Hyku Scientific Co-Founder 12-Nov-2024 Lexington, MA

Fund Team Members (6)

Name Investor Fund Fund Location
Luc Verelst Droia Ventures Droia Ventures III Luxembourg, Luxembourg
Luc Verelst Droia Ventures Droia Ventures IV Luxembourg, Luxembourg
Droia Ventures Luxembourg, Luxembourg
Droia Ventures Luxembourg, Luxembourg
Droia Ventures Luxembourg, Luxembourg

Matthias Van Woensel Ph.D Affiliated Funds (3)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Droia Ventures III Droia Ventures Venture - General Closed 2020
Droia Ventures IV Droia Ventures Venture - General Open 2022
Droia Ventures II Droia Ventures Venture - General Closed 2020

Matthias Van Woensel Ph.D FAQs

  • Who is Matthias Van Woensel Ph.D?

    Dr. Matthias Van Woensel serves as Partner at Droia Oncology Ventures.

  • How much does Matthias Van Woensel Ph.D typically invest?

    Matthias Van Woensel Ph.D's median deal size is .

  • What is Matthias Van Woensel Ph.D’s main position?

    Matthias Van Woensel Ph.D’s primary position is Partner.

  • What are the contact details for Matthias Van Woensel Ph.D?

    Matthias Van Woensel Ph.D’s email address is ma and his phone number is +32 02 .

  • How many active board seats does Matthias Van Woensel Ph.D hold?

    Matthias Van Woensel Ph.D holds 2 board seats including Hillstar Bio and Hyku.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »